ES2128573T3 - Derivados de heparina con actividad antimetastatica. - Google Patents

Derivados de heparina con actividad antimetastatica.

Info

Publication number
ES2128573T3
ES2128573T3 ES94922246T ES94922246T ES2128573T3 ES 2128573 T3 ES2128573 T3 ES 2128573T3 ES 94922246 T ES94922246 T ES 94922246T ES 94922246 T ES94922246 T ES 94922246T ES 2128573 T3 ES2128573 T3 ES 2128573T3
Authority
ES
Spain
Prior art keywords
derivatives
heparine
antimetastatic activity
antimetastatic
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94922246T
Other languages
English (en)
Inventor
Patrizia Caretto
Teresa Sciumbata
Flavio Leoni
Gianni Gromo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Application granted granted Critical
Publication of ES2128573T3 publication Critical patent/ES2128573T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

FRAGMENTOS DE HEPARINA Y FRACCIONES Y/O DERIVADOS QUE POSEEN UNA ACTIVIDAD ANTIMETASTATICA.
ES94922246T 1993-07-12 1994-06-30 Derivados de heparina con actividad antimetastatica. Expired - Lifetime ES2128573T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001518A IT1264709B1 (it) 1993-07-12 1993-07-12 Derivati eparinici ad attivita' antimetastatica

Publications (1)

Publication Number Publication Date
ES2128573T3 true ES2128573T3 (es) 1999-05-16

Family

ID=11366579

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94922246T Expired - Lifetime ES2128573T3 (es) 1993-07-12 1994-06-30 Derivados de heparina con actividad antimetastatica.

Country Status (15)

Country Link
US (2) US5763421A (es)
EP (1) EP0708785B1 (es)
JP (1) JPH08512353A (es)
AT (1) ATE177433T1 (es)
AU (1) AU7345194A (es)
CA (1) CA2167059A1 (es)
DE (1) DE69417035T2 (es)
DK (1) DK0708785T3 (es)
ES (1) ES2128573T3 (es)
FI (1) FI960130A0 (es)
GR (1) GR3029861T3 (es)
IL (1) IL110287A0 (es)
IT (1) IT1264709B1 (es)
WO (1) WO1995002613A2 (es)
ZA (1) ZA945005B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151099B2 (en) 1998-07-31 2006-12-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US8304390B2 (en) * 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US7345039B2 (en) * 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US8030301B2 (en) * 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7892530B2 (en) * 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
CZ20014665A3 (cs) * 1999-06-30 2002-05-15 Hamilton Civic Hospitals Research Development, Inc Prostředek s obsahem heparinu se střední molekulovou hmotností
US6641571B2 (en) 2000-01-05 2003-11-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
US7781416B2 (en) 2000-01-25 2010-08-24 Sigma-Tau Research Switzerland S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
US20040038932A1 (en) * 2000-09-08 2004-02-26 Jack Hirsh Antithrombotic compositions
CZ307433B6 (cs) * 2001-09-12 2018-08-22 Leadiant Biosciences Sa Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US7538096B2 (en) * 2004-03-16 2009-05-26 The General Hospital Corporation Treatment and prevention of abnormal cellular proliferation
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2567079T3 (es) * 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
WO2011090948A1 (en) * 2010-01-19 2011-07-28 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
US9387256B2 (en) 2010-04-16 2016-07-12 Momenta Pharmaceuticals, Inc. Tissue targeting
WO2011159770A2 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
JP6132302B2 (ja) * 2013-05-28 2017-05-24 リーディアント・バイオサイエンシーズ・ソシエタ・アノニマＬｅａｄｉａｎｔ Ｂｉｏｓｃｉｅｎｃｅｓ Ｓ．Ａ． 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
JP2016014148A (ja) * 2015-09-10 2016-01-28 シグマ−タウ・リサーチ・スウィッツァーランド・ソシエテ・アノニム 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1987M (fr) * 1961-08-01 1963-08-26 Evans Medical Ltd Médicament antilipémique a base d'héparine modifiée.
US3118816A (en) * 1962-04-03 1964-01-21 Abbott Lab N-succinyl heparin and process
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
US5280016A (en) * 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
WO1994020512A2 (en) * 1993-03-01 1994-09-15 Glycan Pharmaceuticals, Inc. Analogs for specific oligosaccharide-protein interactions and uses therefor

Also Published As

Publication number Publication date
US5763421A (en) 1998-06-09
WO1995002613A3 (en) 1995-03-09
FI960130A7 (fi) 1996-01-11
IL110287A0 (en) 1994-10-21
DE69417035D1 (de) 1999-04-15
WO1995002613A2 (en) 1995-01-26
ZA945005B (en) 1995-02-21
CA2167059A1 (en) 1995-01-26
EP0708785B1 (en) 1999-03-10
FI960130L (fi) 1996-01-11
ITMI931518A1 (it) 1995-01-12
JPH08512353A (ja) 1996-12-24
GR3029861T3 (en) 1999-07-30
AU7345194A (en) 1995-02-13
FI960130A0 (fi) 1996-01-11
IT1264709B1 (it) 1996-10-04
EP0708785A1 (en) 1996-05-01
ATE177433T1 (de) 1999-03-15
ITMI931518A0 (it) 1993-07-12
DK0708785T3 (da) 1999-10-04
US6130210A (en) 2000-10-10
DE69417035T2 (de) 1999-08-05

Similar Documents

Publication Publication Date Title
ES2128573T3 (es) Derivados de heparina con actividad antimetastatica.
MX164277B (es) Guante que tiene caracteristicas mejoradas de aseguramiento de pueos
BR8903283A (pt) Composicao de vidro cinzento neutro,e lamina de vidro
DE69033867D1 (de) Optischer Verstärker und optisches Übertragungssystem damit
BR8801853A (pt) Montagem de ferramenta,componentes de ferramenta e metodo de montagem dos componentes da mesma
FI962444L (fi) Uusia sellulaasientsyymejä ja systeemejä niiden ilmentämiseksi
IT1244438B (it) Nerofumo e composizioni elastomeriche che contengono il nerofumo.
FI941787A7 (fi) Sähkökirurginen prosessori ja menetelmä sen käyttämiseksi
NO893102L (no) Syns- og hoerselsvern.
FI881936A0 (fi) Foerfarande och anordning i en kombinationstork som bestaor av en gasinfraanordning och en virvelanordning.
FI892890L (fi) Menetelmä ja järjestely optisen vastaanottimen etuasteen dynamiikka-alueen kasvattamiseksi
FI970502L (fi) Makrofagiperäinen kemokiini ja kemokiinijohdannaisia
BR8901727A (pt) Composicao organopolissiloxana estavel em ausencia de unidade e endurecivel em um elastomero
ES2186807T3 (es) Inhibidores de trombina.
DE69010794D1 (de) Fluorborsilikatglas und beschichteter Gegenstand.
ATE58636T1 (de) Gamma-thiobutyrolactonderivate gegen krampf.
ES1009892Y (es) Napa de fibras.
FI955537A7 (fi) Fibrinolyyttiset ja hyytymistä estävät proteiinit
ES2062754T3 (es) Eliminacion de linfocitos activados.
IT1316051B1 (it) Procedimento di sintesi di derivati di esaazaisowurtzitano e formapolimorfa alfa di un derivato di esaazaisowurtzitano.
ITMI940025A0 (it) Derivati di piperazin e piperidinisossazolo
KR900003077U (ko) 창호의 기밀 유지용 피스(piece)
BR7100313U (pt) Conjunto de pa e helice bipartidas com borda recambiavel
IT8620463A0 (it) Procedimento di purificazione di eparine, frazioni e frammenti eparinici.
ITPD940180A0 (it) Procedimento per limitare la trasparenza di vetro piano e/o curvo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708785

Country of ref document: ES